Supriya Lifescience Limited (NSE: SUPRIYA) falls 5% intraday to ₹922.2, breaking below its support line in the Healthcare » Biotechnology sector.
Supriya Lifescience Limited (NSE: SUPRIYA) stock price moves up 6% intraday to ₹1030.45, extending gains in the Healthcare » Biotechnology sector. .
Dishman Carbogen Amcis Limited announces CARBOGEN AMCIS AG's 1,200 kWp solar power plant launch, underscoring commitment to sustainability.
Blue Jet Healthcare Limited (NSE: BLUEJET) gains 5% intraday to ₹542.75, showing a breakout trend with price 12.0% above resistance at ₹477..
Biocon Limited (BIOCON) partners with Duopharma Biotech to secure insulin contracts in Malaysia, valued at over MYR 225 million.
Supriya Lifescience Limited (NSE: SUPRIYA) stock price moves up 5% intraday to ₹974.0, extending gains in the Healthcare » Biotechnology sector.
Panacea Biotec Limited (NSE: PANACEABIO) launches DE NSTAR project to advance dengue vaccine DengiA/1 licensure in Sub-Saharan Africa.
Supriya Lifescience Limited (SUPRIYA) reports a 50% YoY revenue surge in Q4 FY26, driven by strong performance across therapeutic segments.
Blue Jet Healthcare Limited (BLUEJET) reported a 22% QoQ increase in revenue for Q4 FY26, with PAT rising by 60%.
Zota Health Care Limited (ZOTA) reports strong FY26 results with revenue up 83.86% YoY, EBITDA at ₹2,597.73 lakhs, and expansion to 2,579 stores.